Pharmaceutical Residues
Pharmaceutical Residues - Related Videos
07:00
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
0 Views •
Cited by 2 •
2017
The lack of a well-defined procedure that consistently cleaned coupon surfaces was identified as the major contributor to low and variable recoveries in cleaning verification. This manuscript describes the correct protocol of cleaning stainless steel coupons.
01:26
Pharmaceutical Equivalents
0 Views •
2025
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:30
Production of Pharmaceuticals
0 Views •
2026
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:26
Residual Stresses
0 Views •
2024
Residual stresses reside in a structure even after removing the original stress inducer. This phenomenon often arises from varied plastic deformations across different parts of a structure. Consider a rod stretched beyond its yield point. It will not regain its original length due to permanent deformation. Even after load removal, the rod does not entirely lose stress because of uneven plastic deformations, resulting in residual stresses. The computation of these stresses in structures is...
01:07
Residual Plots
0 Views •
2023
A residual plot is a statistical representation of data used to analyze correlation and regression results. It helps verify the requirements for drawing specific conclusions about correlation and regression. To obtain the residual plot, first, the residual for each data value is calculated, which is simply the vertical distance between the observed and the predicted value obtained from the regression equation. When the residual values are plotted against the variable x, it is called a residual...
FAQs
Solubility influences whether a compound remains dissolved and how it moves through wastewater or surface water, while chemical stability affects how long it remains intact. Resistance to biodegradation can prolong persistence when microbial activity does not readily break the compound down. Together, these properties help explain differences in transport, treatment behavior, and environmental concentration.
These processes alter residues through different chemical or biological pathways. Hydrolysis uses reactions involving water, photolysis is driven by light, and microbial activity depends on organisms that transform compounds during environmental or treatment processes. The resulting transformation products may differ from the original medicines, so chemical analysis must consider both parent compounds and products when evaluating persistence.
Their treatment behavior depends on compound-specific chemical properties rather than on pharmaceutical use alone. Solubility affects movement through the treatment system, stability influences whether the original structure remains intact, and biodegradation resistance limits removal by microbial processes. Examining these factors helps chemists interpret why some residues persist, transform, or decrease in concentration during treatment.
Chromatography separates compounds in a sample, while mass spectrometry helps identify and measure them based on their chemical signals. Applied to wastewater, surface water, soil, or other media, this combination can reveal which residues are present and at what concentrations. The measurements support source identification, pollution monitoring, and evaluation of treatment performance.
A study first selects relevant environmental media, such as wastewater, surface water, or soil, and then analyzes samples for parent medicines and transformation products. Chromatographic separation followed by mass spectrometric measurement provides chemical identification and concentration data. Comparing results across locations or treatment stages can indicate possible sources and show how residues change through environmental systems.
Researchers use the measurements to compare residue concentrations before and after treatment and to determine whether compounds are removed or transformed. Chemical data can reveal limitations in treatment performance and distinguish a decline in the original medicine from the formation of transformation products. This evidence supports improved wastewater treatment and more informed pollution monitoring.
Chemical analysis provides evidence about where residues occur, how much is present, and whether they persist or transform. Those findings contribute to environmental risk assessment and help identify compounds that warrant closer monitoring. The same knowledge can guide development of more environmentally sustainable pharmaceuticals by linking molecular properties with environmental fate and treatment behavior.